PL375142A1 - Farmaceutyczna postać leku do podawania przez śluzówkę - Google Patents

Farmaceutyczna postać leku do podawania przez śluzówkę

Info

Publication number: PL375142A1
Authority: PL; Poland
Prior art keywords: administration form; pharmaceutical administration; transmucosal pharmaceutical; transmucosal; pharmaceutical
Prior art date: 2002-11-08

Application number

PL03375142A

Other languages

English (en)

Inventor

Hans-Rainer Hoffmann

Von Reinhard Kleinsorgen

Werner Wessling

Original Assignee

Lts Lohmann Therapie-Systeme Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-08

Filing date

2003-10-17

Publication date

2005-11-28

2003-10-17 Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag

2005-11-28 Publication of PL375142A1 publication Critical patent/PL375142A1/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL03375142A 2002-11-08 2003-10-17 Farmaceutyczna postać leku do podawania przez śluzówkę PL375142A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10251963A DE10251963A1 (de)	2002-11-08	2002-11-08	Transmucosale pharmazeutische Darreichungsform

Publications (1)

Publication Number	Publication Date
PL375142A1 true PL375142A1 (pl)	2005-11-28

Family

ID=32115381

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL03375142A PL375142A1 (pl)	2002-11-08	2003-10-17	Farmaceutyczna postać leku do podawania przez śluzówkę

Country Status (14)

Country	Link
US (1)	US20060013864A1 (pl)
EP (1)	EP1558209A1 (pl)
JP (1)	JP2006506406A (pl)
KR (1)	KR20050084938A (pl)
CN (1)	CN1694685A (pl)
AU (1)	AU2003274030B2 (pl)
BR (1)	BR0315911A (pl)
CA (1)	CA2497848A1 (pl)
DE (1)	DE10251963A1 (pl)
MX (1)	MXPA05004892A (pl)
PL (1)	PL375142A1 (pl)
RU (1)	RU2342925C2 (pl)
WO (1)	WO2004041239A1 (pl)
ZA (1)	ZA200502443B (pl)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3706831A (en) *	1971-05-14	1972-12-19	Abbott Lab	Method for treatment of drug addiction
SE8206744D0 (sv) *	1982-11-26	1982-11-26	Fluidcarbon International Ab	Preparat for kontrollerad avgivning av substanser
JPS6115829A (ja) *	1984-06-29	1986-01-23	Toyobo Co Ltd	口腔粘膜適用徐放性ニフエジピン製剤
DE3910543A1 (de) *	1989-04-01	1990-10-11	Lohmann Therapie Syst Lts	Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US5079018A (en) *	1989-08-14	1992-01-07	Neophore Technologies, Inc.	Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5998409A (en) *	1992-03-12	1999-12-07	Smithkline Beecham Plc	Condensed indole derivatives as 5HT4 -receptor antagonists
US5977144A (en)	1992-08-31	1999-11-02	University Of Florida	Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
US5817679A (en) *	1993-04-01	1998-10-06	University Of Virginia	7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
US5453523A (en) *	1993-06-16	1995-09-26	Emulsion Technology, Inc.	Process for obtaining highly purified phosphatidylcholine
HUT74949A (en) *	1993-09-10	1997-03-28	Cytomed	Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
US6117889A (en) *	1994-04-01	2000-09-12	University Of Virginia	7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents
JPH07291854A (ja) *	1994-04-26	1995-11-07	Tanabe Seiyaku Co Ltd	溶解性の改善された医薬品製剤
WO1996000072A1 (en) *	1994-06-23	1996-01-04	The Procter & Gamble Company	Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
DE19701949A1 (de) *	1997-01-13	1998-07-16	Jenapharm Gmbh	Transdermales therapeutisches System
AU750808B2 (en) *	1997-10-03	2002-07-25	Cary Medical Corporation	Compositon for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug
US20040028735A1 (en) *	1997-11-14	2004-02-12	Unchalee Kositprapa	Pharmaceutical formulation
SE9803986D0 (sv) *	1998-11-23	1998-11-23	Pharmacia & Upjohn Ab	New compositions
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AR025609A1 (es) *	1999-09-13	2002-12-04	Hoffmann La Roche	Formulaciones lipidas solidas
US6264981B1 (en) *	1999-10-27	2001-07-24	Anesta Corporation	Oral transmucosal drug dosage using solid solution
DE10024413A1 (de) *	2000-05-19	2001-12-06	Mika Pharma Gmbh	Pharmazeutische und/oder kosmetische Zubereitung
DE10032456A1 (de) *	2000-07-04	2002-01-31	Lohmann Therapie Syst Lts	Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen
DE10107659B4 (de) *	2001-02-19	2008-03-13	Lts Lohmann Therapie-Systeme Ag	Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin

2002
- 2002-11-08 DE DE10251963A patent/DE10251963A1/de not_active Withdrawn
2003
- 2003-10-17 US US10/533,926 patent/US20060013864A1/en not_active Abandoned
- 2003-10-17 CN CNA2003801007385A patent/CN1694685A/zh active Pending
- 2003-10-17 KR KR1020057007931A patent/KR20050084938A/ko not_active Ceased
- 2003-10-17 CA CA002497848A patent/CA2497848A1/en not_active Abandoned
- 2003-10-17 BR BR0315911-6A patent/BR0315911A/pt not_active IP Right Cessation
- 2003-10-17 EP EP03758008A patent/EP1558209A1/de not_active Ceased
- 2003-10-17 MX MXPA05004892A patent/MXPA05004892A/es active IP Right Grant
- 2003-10-17 JP JP2004548754A patent/JP2006506406A/ja active Pending
- 2003-10-17 RU RU2005113169/15A patent/RU2342925C2/ru not_active IP Right Cessation
- 2003-10-17 PL PL03375142A patent/PL375142A1/pl not_active Application Discontinuation
- 2003-10-17 WO PCT/EP2003/011529 patent/WO2004041239A1/de not_active Ceased
- 2003-10-17 AU AU2003274030A patent/AU2003274030B2/en not_active Ceased
2005
- 2005-03-24 ZA ZA200502443A patent/ZA200502443B/en unknown

Also Published As

Publication number	Publication date
EP1558209A1 (de)	2005-08-03
MXPA05004892A (es)	2005-07-22
RU2342925C2 (ru)	2009-01-10
JP2006506406A (ja)	2006-02-23
CA2497848A1 (en)	2004-05-21
DE10251963A1 (de)	2004-05-19
WO2004041239A1 (de)	2004-05-21
KR20050084938A (ko)	2005-08-29
CN1694685A (zh)	2005-11-09
ZA200502443B (en)	2005-09-26
BR0315911A (pt)	2005-09-13
AU2003274030A1 (en)	2004-06-07
AU2003274030B2 (en)	2008-09-04
US20060013864A1 (en)	2006-01-19
RU2005113169A (ru)	2006-01-20

Legal Events

Date	Code	Title	Description
2013-01-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
GB0117618D0 (en)	2001-09-12	Pharmaceutical dosage form
IL166286A0 (en)	2006-01-15	Multicomponent pharmaceutical dosage form
GB0210397D0 (en)	2002-06-12	Pharmaceutical formulations
IL165480A0 (en)	2006-01-15	Topical drug delivery using phosphatidylcholine
PT1362582E (pt)	2008-01-22	Forma de dosagem sólida revestida
AU2003291103A8 (en)	2004-06-15	Pharmaceutical composition
IL154012A0 (en)	2003-07-31	Hydrogel-driven drug dosage form
GB0117619D0 (en)	2001-09-12	Pharmaceutical dosage form
IL164547A0 (en)	2005-12-18	Pharmaceutical composition
IL165878A0 (en)	2006-01-15	Pharmaceutical composition
HUP0303948A2 (hu)	2004-04-28	Szájban diszpergálódó szilárd gyógyszerforma
GB2392093B (en)	2006-03-08	Pharmaceutical formulations
IL169083A (en)	2010-11-30	Medication administration system
GB0206505D0 (en)	2002-05-01	Pharmaceutical combination
PL373409A1 (pl)	2005-08-22	Kombinacja farmaceutyczna
GB0201520D0 (en)	2002-03-13	Pharmaceutical uses
GB0215593D0 (en)	2002-08-14	New anticancer drugs
PL375142A1 (pl)	2005-11-28	Farmaceutyczna postać leku do podawania przez śluzówkę
HU0200337D0 (en)	2002-03-28	Stabilised pharmaceutical composition
GB0217703D0 (en)	2002-09-11	Pharmaceutical composition
AU2003238900A8 (en)	2003-12-22	Pharmaceutical formulation
GB0217336D0 (en)	2002-09-04	Multicomponent pharmaceutical dosage form
GB0224680D0 (en)	2002-12-04	Pharmaceutical
GB0217478D0 (en)	2002-09-04	Multiple-therapy drug delivery
GB0209411D0 (en)	2002-06-05	Drug delivery